The structure of a dual-specificity tyrosine phosphorylation-regulated kinase 1A-PKC412 complex reveals disulfide-bridge formation with the anomalous catalytic loop HRD(HCD) cysteine

被引:30
作者
Alexeeva, Marina [1 ]
Aberg, Espen [1 ]
Engh, Richard A. [1 ]
Rothweiler, Ulli [1 ]
机构
[1] Arctic Univ Norway, Dept Chem, Norwegian Struct Biol Ctr, N-9037 Tromso, Norway
来源
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY | 2015年 / 71卷
关键词
DYRK kinase; disulfide bridge; PKC412; midostaurin; inhibitor; redox; DEPENDENT PROTEIN-KINASE; DOWN-SYNDROME; REDOX REGULATION; DYRK1A; INHIBITOR; FLT3; MIRK/DYRK1B; ACTIVATION; DISEASE; FAMILY;
D O I
10.1107/S1399004715005106
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a protein kinase associated with neuronal development and brain physiology. The DYRK kinases are very unusual with respect to the sequence of the catalytic loop, in which the otherwise highly conserved arginine of the HRD motif is replaced by a cysteine. This replacement, along with the proximity of a potential disulfide-bridge partner from the activation segment, implies a potential for redox control of DYRK family activities. Here, the crystal structure of DYRK1A bound to PKC412 is reported, showing the formation of the disulfide bridge and associated conformational changes of the activation loop. The DYRK kinases represent emerging drug targets for several neurological diseases as well as cancer. The observation of distinct activation states may impact strategies for drug targeting. In addition, the characterization of PKC412 binding offers new insights for DYRK inhibitor discovery.
引用
收藏
页码:1207 / 1215
页数:9
相关论文
共 61 条
[1]   PHENIX: a comprehensive Python']Python-based system for macromolecular structure solution [J].
Adams, Paul D. ;
Afonine, Pavel V. ;
Bunkoczi, Gabor ;
Chen, Vincent B. ;
Davis, Ian W. ;
Echols, Nathaniel ;
Headd, Jeffrey J. ;
Hung, Li-Wei ;
Kapral, Gary J. ;
Grosse-Kunstleve, Ralf W. ;
McCoy, Airlie J. ;
Moriarty, Nigel W. ;
Oeffner, Robert ;
Read, Randy J. ;
Richardson, David C. ;
Richardson, Jane S. ;
Terwilliger, Thomas C. ;
Zwart, Peter H. .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2010, 66 :213-221
[3]   Pyrido[2,3-d]pyrimidines: Discovery and preliminary SAR of a novel series of DYRK1B and DYRK1A inhibitors [J].
Anderson, Kevin ;
Chen, Yi ;
Chen, Zhi ;
Dominique, Romyr ;
Glenn, Kelli ;
He, Yang ;
Janson, Cheryl ;
Luk, Kin-Chun ;
Lukacs, Christine ;
Polonskaia, Ann ;
Qiao, Qi ;
Railkar, Aruna ;
Rossman, Pamela ;
Sun, Hongmao ;
Xiang, Qing ;
Vilenchik, Masha ;
Wovkulich, Peter ;
Zhang, Xiaolei .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (24) :6610-6615
[4]   DYRK family of protein kinases: evolutionary relationships, biochemical properties, and functional roles [J].
Aranda, Sergi ;
Laguna, Ariadna ;
de la Luna, Susana .
FASEB JOURNAL, 2011, 25 (02) :449-462
[5]  
Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1
[6]   Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases [J].
Becker, W ;
Weber, Y ;
Wetzel, K ;
Eirmbter, K ;
Tejedor, FJ ;
Joost, HG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (40) :25893-25902
[7]   DYRK1A: A Potential Drug Target for Multiple Down Syndrome Neuropathologies [J].
Becker, Walter ;
Soppa, Ulf ;
Tejedor, Francisco J. .
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (01) :26-33
[8]   Activation, regulation, and inhibition of DYRK1A [J].
Becker, Walter ;
Sippl, Wolfgang .
FEBS JOURNAL, 2011, 278 (02) :246-256
[9]   A quantitative model of thermal stabilization and destabilization of proteins by ligands [J].
Cimmperman, Piotras ;
Baranauskiene, Lina ;
Jachimoviciute, Simona ;
Jachno, Jelena ;
Torresan, Jolanta ;
Michailoviene, Vilma ;
Matuliene, Jurgita ;
Sereikaite, Jolanta ;
Bumelis, Vladas ;
Matulis, Daumantas .
BIOPHYSICAL JOURNAL, 2008, 95 (07) :3222-3231
[10]  
ClinicalTrials, 2014, DAUN CYT MID TREAT P